Progyny, Inc. Announces Details for Its Third Quarter 2026 Results ReportGlobeNewsWire · 3 days ago
Progyny (NASDAQ:PGNY) COO Sells $52,612.00 in StockDefense World · 6 days ago
Progyny to Present New Menopause Research at The Menopause Society 2026 Annual MeetingGlobeNewsWire · Oct 15, 2026
Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock?Zacks Investment Research · Oct 8, 2026
PGNY or CRL: Which Is the Better Value Stock Right Now?Zacks Investment Research · Oct 7, 2026
Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market DynamicsGlobeNewsWire · Oct 7, 2026Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | $0.33 | $0.36 | Beat |
| May 7, 2026 | $0.26 | $0.30 | Beat |
| Feb 26, 2026 | $0.15 | $0.15 | Beat |
| Nov 6, 2025 | $0.39 | $0.16 | Miss |
| Aug 7, 2025 | $0.17 | $0.20 | Beat |
| May 8, 2025 | $0.19 | $0.18 | Miss |